Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type  | Year | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| AstraZeneca | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $24,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $20,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $13,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $90,000,000 |
| Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $800,000 |
| Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $3,500,000 |
| Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
| Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $13,000,000 |
| Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $4,150,000 |
| Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $2,100,000 |
| Bausch & Lomb Inc. | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $10,000,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $50,000,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,800,000 |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,000,000 |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $19,000,000 |
| CSL Limited | CSL Limited | pharmaceuticals | price-fixing or anti-competitive practices | 2014 | private lawsuit-federal | $64,000,000 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
| Dey, Inc. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Dr. Reddy's Laboratories Ltd. | Dr. Reddy's Laboratories | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $400,000 |
| E. Merck KG | Merck KGaA (EMD) | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | private lawsuit-federal | $50,000,000 |
| Eisai Company | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
| Fujisawa Healthcare, Inc. | Astellas Pharma | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
| GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $21,500,000 |
| GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $70,000,000 |
| Hoechst AG | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $37,000,000 |
| Hoechst Marion Roussel | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Hoechst Marion Roussel, Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2016 | private lawsuit-state | $50,000,000 |
| Hoffmann-La Roche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $130,000,000 |
| Hoffmann-La Roche Inc. | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | private lawsuit-federal | $11,000,000 |
| Immunex Corporation | Amgen | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Impax Laboratories, Inc. | Amneal Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $15,000,000 |
| Impax Laboratories, Inc. | Amneal Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $20,000,000 |
| Johnson & Johnson Vision Care Inc. | Johnson & Johnson | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $55,000,000 |
| Lupin Ltd. | Lupin Limited | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $625,000 |
| Lupin Ltd. | Lupin Limited | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $1,143,750 |
| Lupin Pharmaceuticals Inc. | Lupin Limited | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $1,000,000 |
| Medicis Pharmaceutical Corp. | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $23,000,000 |
| Merck & Co. | Merck | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $60,200,000 |
| Momenta Pharmaceuticals Inc. | Johnson & Johnson | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $35,000,000 |
| Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $2,000,000 |
| Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $9,000,000 |
| Mylan Inc. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $14,377,600 |
| Mylan Inc. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $57,000,000 |
| Mylan Inc. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $65,000,000 |
| Novo Nordisk A/S | Novo Holdings A/S | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $19,000,000 |
| Organon Inc. | Organon & Co. | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
| Pharmacia Corporation | Pfizer | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Purdue Pharma L.P. | Purdue Pharma | pharmaceuticals | price-fixing or anti-competitive practices | 2010 | private lawsuit-federal | $16,000,000 |
| Ranbaxy Laboratories Ltd. | Sun Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $3,500,000 |
| Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $1,750,000 |
| Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $3,202,500 |
| Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $85,000,000 |
| Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $150,000,000 |
| Sanofi Pasteur Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $61,500,000 |
| Schering-Plough Corporation | Merck | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $55,000,000 |
| Shire LLC | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $1,850,000 |
| Shire US Inc. | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $14,750,000 |
| Sun Pharmaceuticals Industries Ltd | Sun Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $400,000 |
| Sun Pharmaceuticals Industries Ltd | Sun Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $17,357,000 |
| Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
| Takeda Chemical Industries Ltd. | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $22,000,000 |
| TAP Pharmaceutical Products | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $150,000,000 |
| Taro Pharmaceutical USA Inc. | Sun Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $67,643,000 |
| Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $24,000,000 |
| UCB Chemicals Corporation | UCB | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | private lawsuit-federal | $9,000,000 |
| Valeant Pharmaceuticals International, Inc. | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $23,000,000 |
| Valeant Pharmaceuticals International, Inc. | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,750,000 |
| Warner Chilcott | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $8,000,000 |
| Warner Chilcott Holdings Company | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | private lawsuit-federal | $9,000,000 |
| Warner Chilcott Holdings Company | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $4,150,000 |
| Warner Chilcott Holdings Company | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $2,100,000 |
| Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $27,000,000 |
| Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $79,000,000 |
| Wockhardt Limited | Wockhardt Limited | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $340,000 |
| Wyeth | Pfizer | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $2,100,000 |
| ZLB Behring, L.L.C. | CSL Limited | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | MULTI-AG | $102,500,000 |
| Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $275,000,000 |
| Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $30,000,000 |
| Glenmark Pharmaceuticals | Glenmark Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $14,000,000 |
| Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $30,000,000 |
| Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $385,000,000 |
| EMD Millipore Corporation | Merck KGaA (EMD) | pharmaceuticals | pesticide violation | 2013 | EPA | $2,681,500 |
| Advanced Sterilization Products | Johnson & Johnson | pharmaceuticals | pesticide violation | 2012 | CA-DPR | $25,616 |
| Pfizer Inc. | Pfizer | pharmaceuticals | pesticide violation | 2012 | CA-DPR | $6,720 |
| Schering-Plough Healthcare Products Inc. | Merck | pharmaceuticals | pesticide violation | 2011 | CA-DPR | $28,400 |
| Abbott Laboratories Diagnostics | Abbott Laboratories | pharmaceuticals | pesticide violation | 2007 | CA-DPR | $9,476 |
| E.R. Squibb & Sons LLC | Bristol-Myers Squibb | pharmaceuticals | PCB violation | 2009 | EPA | $8,125 |
| Pfizer Pharmaceuticals | Pfizer | pharmaceuticals | PCB violation | 2010 | EPA | $24,650 |
| Celgene Corporation | Bristol-Myers Squibb | pharmaceuticals | PCB violation | 2013 | EPA | $6,035 |
| Endo Health Solutions Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | FDA | $192,700,000 |
| Wyeth Pharmaceuticals Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $490,900,000 |
| Par Pharmaceutical Companies Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $45,000,000 |
| Abbott Laboratories Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $1,500,000,000 |
| Cypress Pharmaceutical Inc. | Currax Pharmaceuticals | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $2,800,000 |
| Merck, Sharp & Dohme | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $950,000,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $14,500,000 |
